Evidence map›Paper›PMID 9675164›Full record

ArticleBiophysical journal1998

Opioid receptor three-dimensional structures from distance geometry calculations with hydrogen bonding constraints.

I D Pogozheva, A L Lomize, H I Mosberg

Abstract read
In one paragraph

Article in Biophysical journal, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. μ-Opioid receptor 6-transmembrane isoform: A potential therapeutic target for new effective opioids.Progress in neuro-psychopharmacology & biological psychiatry · 2015
    Review
  7. Article
  8. Article
  9. [Medicine from the computer].Zeitschrift fur Rheumatologie · 2013
    Article
  10. [Medicine from the computer].Schmerz (Berlin, Germany) · 2013
    Article
  11. [Medicine from the computer].Der Anaesthesist · 2013
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

I D PogozhevaCollege of Pharmacy, University of Michigan, Ann Arbor, Michigan 48109 USA.
A L Lomize
H I Mosberg

Funding

Development of Mixed Function Opioid Peptides and PeptidomimeticsR01DA003910 · NIDA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MOSBERG, HENRY ISAAC · 1985 to 2017
$9.0M
MODELING THE 3D STRUCTURE OF OPIOID RECEPTORSR55DA009989 · NIDA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MOSBERG, HENRY ISAAC · 1996 to 1996
–
NIDA NIH HHS DA00118NIDA NIH HHS DA03910NIDA NIH HHS DA09989
6 · The paper itself

Abstract

Three-dimensional structures of the transmembrane, seven alpha-helical domains and extracellular loops of delta, mu, and kappa opioid receptors, were calculated using the distance geometry algorithm, with hydrogen bonding constraints based on the previously developed general model of the transmembrane alpha-bundle for rhodopsin-like G-protein coupled receptors (Biophys. J. 1997. 70:1963). Each calculated opioid receptor structure has an extensive network of interhelical hydrogen bonds and a ligand-binding crevice that is partially covered by a beta-hairpin formed by the second extracellular loop. The binding cavities consist of an inner "conserved region" composed of 18 residues that are identical in delta, mu, and kappa opioid receptors, and a peripheral "variable region," composed of 19 residues that are different in delta, mu, and kappa subtypes and are responsible for the subtype specificity of various ligands. Sixteen delta-, mu-, or kappa-selective, conformationally constrained peptide and nonpeptide opioid agonists and antagonists and affinity labels were fit into the binding pockets of the opioid receptors. All ligands considered have a similar spatial arrangement in the receptors, with the tyramine moiety of alkaloids or Tyr1 of opioid peptides interacting with conserved residues in the bottom of the pocket and the tyramine N+ and OH groups forming ionic interactions or H-bonds with a conserved aspartate from helix III and a conserved histidine from helix VI, respectively. The central, conformationally constrained fragments of the opioids (the disulfide-bridged cycles of the peptides and various ring structures in the nonpeptide ligands) are oriented approximately perpendicular to the tyramine and directed toward the extracellular surface. The results obtained are qualitatively consistent with ligand affinities, cross-linking studies, and mutagenesis data.

Indexed as

Protein Structure, SecondaryAlgorithmsAmino Acid SequenceBenzomorphansBinding SitesCell MembraneEnkephalin, D-Penicillamine (2,5)-EnkephalinsGTP-Binding ProteinsHydrogen BondingLigandsModels, ChemicalModels, MolecularMolecular Sequence DataMorphinansPeptides, CyclicBenzomorphansEnkephalin, D-Penicillamine (2,5)-EnkephalinsGTP-Binding ProteinsLigandsMorphinansPeptides, CyclicReceptors, Opioid, deltaReceptors, Opioid, kappaReceptors, Opioid, muRhodopsin

Identifiers

PMID9675164
PMCPMC1299737

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.